ABOUT: Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Spectrum Pharmaceuticals Incorporated - symbol SPPI - reported that the FDA has granted FUSILEV (levoleucovorin) “Orphan Drug” exclusivity for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer. In addition, FUSILEV therapeutic compositions are protected under a US Patent which expires at the end of December 2019 and the company has already filed a patent extension application. Spectrum Pharmaceuticals is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera